Clinasia
Services >> Phase IV >> Early Post-Approval Planning
     
  Early Post-Approval Planning  
     
 

ClinAsia Labs extends its services beyond the completion of the study. ClinAsia Labs has earned the capability to analyze the market and help its clients in post approval planning right from Manufacturing, Supply Chain Management, Go to Market Strategies, Marketing Intelligence and so on.

Our Services in this area include

  • Ensure fulfillment of regulatory commitments
  • Promote adherence to treatment regimens with patient adherence programs
  • Develop  indications, delivery systems and patent retentions with late-stage trials
  • Examine off-label usage in investigator-initiated trials
  • Ensure long-term safety and determine optimal use with in observational studies
  • Provide customer support and adverse event collection
  • Coordinate ongoing safety assessments and regulatory
 
     
     
  Early Post-Approval Planning  
  Product Safety and Pharmacovigilance  
  Late Stage research services  
  Registries and Observational Studies  
     
 
 
ClinAsia Labs successfully provided services to a fortune 500 pharma company in the area of clinical data management.

-----------------------------------------------
ClinAsia Labs has provided end to end clinical research services in the field of Neurology to a global pharma company.

-----------------------------------------------
ClinAsia Labs has recently completed a study pathology with its expertise in the areas of EDC and Regulatory affairs for a global pharma company.

-----------------------------------------------
ClinAsia Labs successfully provided services to a fortune 500 pharma company in the area of clinical data management.

-----------------------------------------------
ClinAsia Labs has provided end to end clinical research services in the field of Neurology to a global pharma company.

-----------------------------------------------
ClinAsia Labs has recently completed a study pathology with its expertise in the areas of EDC and Regulatory affairs for a global pharma company.

-----------------------------------------------
 
 
 
   
   
   
   
 
     
 Copyright © 2008-2009. All Rights Reserved.  Sitemap | Legal Disclaimer